Foresite Capital
Funding rounds backed by Foresite Capital.
- Funding disclosed in full
- $881M
- Median round
- $100M
- Rounds in calculation
- 7
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Abcuro Develops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases | $66MSeries D | BiotechUnited States | 17 participantsabrdnBain Capital Life SciencesEurofarma VenturesForesite CapitalKaitai CapitalMass General Brigham VenturesNancy ChangNew Enterprise Associates (NEA)New Leaf Venture PartnersPontifaxRA Capital ManagementRedmile GroupRock Springs CapitalSamsara BioCapitalSanofi VenturesShang BaySoleus Capital | ||
| Khartis Therapeutics Develops oral small molecule therapies for immunological and chronic diseases | $50MSeries B | BiotechUnited States | |||
| Stepful Offers accelerated, affordable training for healthcare careers | $55MSeries C | HealthtechUnited States | |||
| Slate Medicines Advancing next-generation therapeutics for migraine and other headache disorders | $130MSeries A | BiotechUnited States | |||
| Korsana Biosciences Develops novel therapies to reduce the burden of neurodegenerative diseases | $175MSeries A | BiotechUnited States | |||
| Midi Health Provides accessible, insurance-covered services in all 50 states for women's healthcare | $100MSeries D | HealthtechUnited States | |||
| Parabilis Medicines Develops medicines targeting historically undruggable protein targets in cancer | $305MSeries F | BiotechUnited States | 23 participantsAlderline GroupARCH Venture PartnersCatalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners |